[Study of a new psychopharmaceutical agent, oxypertine, in anxiety states].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D001008:Anxiety Disorders / Q000188:drug therapy*; D002214:Capsules; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D002214:Capsules; D007211:Indoles; D010879:Piperazines; D014149:Tranquilizing Agents
Estudio de un nuevo psicofarmáco, la oxipertina, en los estados de ansiedad